[慢性骨髓增生性疾病患者免疫功能紊乱严重程度及影响其纠正结果的因素]。

IF 0.2 4区医学 Q4 HEMATOLOGY

Gematologiya I Transfuziologiya Pub Date : 1995-05-01

V I Shardakov, T F Kopaneva, G A Zaĭtseva

{"title":"[慢性骨髓增生性疾病患者免疫功能紊乱严重程度及影响其纠正结果的因素]。","authors":"V I Shardakov, T F Kopaneva, G A Zaĭtseva","doi":"","DOIUrl":null,"url":null,"abstract":"Immune status in relation to tumor progression was evaluated in 175 patients with chronic myeloproliferative diseases. 113 of them had chronic myeloid leukemia, 62 chronic subleukemic myelosis. It was established that immunologic reactivity decline correlated with the rate of tumor progression. The degree of immune deficiency should be taken into consideration in selection of patients for immunotherapy.","PeriodicalId":50427,"journal":{"name":"Gematologiya I Transfuziologiya","volume":"40 3","pages":"6-8"},"PeriodicalIF":0.2000,"publicationDate":"1995-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The degree of severity of immune disorders and factors influencing the results of their correction in patients with chronic myeloproliferative diseases].\",\"authors\":\"V I Shardakov, T F Kopaneva, G A Zaĭtseva\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Immune status in relation to tumor progression was evaluated in 175 patients with chronic myeloproliferative diseases. 113 of them had chronic myeloid leukemia, 62 chronic subleukemic myelosis. It was established that immunologic reactivity decline correlated with the rate of tumor progression. The degree of immune deficiency should be taken into consideration in selection of patients for immunotherapy.\",\"PeriodicalId\":50427,\"journal\":{\"name\":\"Gematologiya I Transfuziologiya\",\"volume\":\"40 3\",\"pages\":\"6-8\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"1995-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gematologiya I Transfuziologiya\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gematologiya I Transfuziologiya","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

对175例慢性骨髓增生性疾病患者的免疫状态与肿瘤进展的关系进行了评估。慢性髓性白血病113例，慢性亚白血病62例。免疫反应性下降与肿瘤进展速度相关。在选择患者进行免疫治疗时应考虑免疫缺陷的程度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[The degree of severity of immune disorders and factors influencing the results of their correction in patients with chronic myeloproliferative diseases].

Immune status in relation to tumor progression was evaluated in 175 patients with chronic myeloproliferative diseases. 113 of them had chronic myeloid leukemia, 62 chronic subleukemic myelosis. It was established that immunologic reactivity decline correlated with the rate of tumor progression. The degree of immune deficiency should be taken into consideration in selection of patients for immunotherapy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Gematologiya I Transfuziologiya 医学-血液学

CiteScore

0.80

自引率

66.70%

发文量

审稿时长

>12 weeks

期刊介绍： The journal publishes original theoretical and clinical studies, lectures, reviews, and practical notes concerning various problems of hematology and clinical and industrial transfusion. The journal provides information on the etiology, pathogenesis, diagnosis and treatment of blood disorders as well as on related non-hematological conditions (internal diseases, poisoning, exposure to ionizing radiation etc.).